• Home
  • »
  • Newsroom
  • »
  • Alexion Provides Update on Business Practices

Alexion Provides Update on Business Practices


Wednesday, May 17, 2017 4:00 pm EDT



Alexion is a company that saves patients’ lives through therapies with proven effectiveness in the treatment of devastating, rare diseases. Our focus on life-saving therapies informs all that we do. We remain fully committed to instilling a culture where high-performing teams embrace quality, responsibility, integrity, and ethical behavior and continue to make investments in talent, training and systems as we grow our business.

The Executive Management team and Board of Directors are committed to ensuring that our business practices in all countries are grounded in responsible and ethical behavior that fully complies with applicable law. Under the leadership of Alexion’s new CEO, Ludwig Hantson, we are actively engaged in a strategic assessment of our organization –including our business operations in Brazil. If improper business practices are found, they will be stopped and remediated. If personnel violate company policy or the law, they will be disciplined appropriately, which may include termination.

We also want stakeholders to know that Alexion’s relationships with physicians, diagnostic laboratories, and our Nurse Case Managers are critical to serving patients suffering from rare diseases. Our interactions with these important partners have been part of our comprehensive assessment and we have recently taken decisive steps, which were communicated to employees earlier this week, to further strengthen our policies and procedures within each of these critical areas.

The fundamentals of Alexion are strong. As the company continues to review and improve its operations, we remain proud of our patient-centric culture and the thousands of employees who work tirelessly to provide patients suffering from devastating diseases with the therapies that help them live productive and fulfilling lives.


Related Materials: